Quality Compliance Coordinator
Regeneron Pharmaceuticals
Summary
Your essential duties and responsibilities include, but are not limited to:
Job description
Discover your role
Your essential duties and responsibilities include, but are not limited to:
- Follow site procedures and maintain compliance
- Get involved as needed to meet schedules or resolve problems
- Monitor the group mailbox for incoming complaint notifications
- Enter complaint intake data into the Quality Management System
- Verify that required documentation and content have been received
- Evaluate each event or complaint and assign an initial classification
- Communicate with personnel and contractors (Call Center, Regeneron Distribution, Clinical Trial Management, etc.) as needed to request or obtain additional information on complaint reports
- Provide general administrative support to the complaint team
What we're looking for
BS/BA in a scientific discipline or related field preferred, with 3+ years of relevant work experience. Relevant experience may be accepted in place of a degree.
Requirements
- BS/BA in a scientific discipline or related field preferred
- 3+ years of relevant work experience
- Relevant experience may be accepted in place of a degree
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.